S&P 500   3,473.86 (+1.37%)
DOW   28,560.38 (+1.29%)
QQQ   286.90 (+1.09%)
AAPL   118.66 (+2.31%)
MSFT   216.24 (+0.94%)
FB   268.77 (+2.82%)
GOOGL   1,556.00 (+1.70%)
AMZN   3,243.68 (+1.14%)
TSLA   428.67 (-0.50%)
NVDA   549.00 (+1.68%)
BABA   311.33 (+1.98%)
CGC   19.21 (-3.03%)
GE   7.37 (+1.10%)
MU   54.12 (+2.83%)
AMD   82.54 (+0.66%)
T   26.94 (+0.22%)
F   7.84 (+3.29%)
ACB   4.51 (-4.25%)
GILD   60.42 (-0.25%)
NFLX   530.11 (-0.11%)
BA   168.39 (+0.77%)
BAC   24.32 (+2.53%)
DIS   125.07 (+0.68%)
S&P 500   3,473.86 (+1.37%)
DOW   28,560.38 (+1.29%)
QQQ   286.90 (+1.09%)
AAPL   118.66 (+2.31%)
MSFT   216.24 (+0.94%)
FB   268.77 (+2.82%)
GOOGL   1,556.00 (+1.70%)
AMZN   3,243.68 (+1.14%)
TSLA   428.67 (-0.50%)
NVDA   549.00 (+1.68%)
BABA   311.33 (+1.98%)
CGC   19.21 (-3.03%)
GE   7.37 (+1.10%)
MU   54.12 (+2.83%)
AMD   82.54 (+0.66%)
T   26.94 (+0.22%)
F   7.84 (+3.29%)
ACB   4.51 (-4.25%)
GILD   60.42 (-0.25%)
NFLX   530.11 (-0.11%)
BA   168.39 (+0.77%)
BAC   24.32 (+2.53%)
DIS   125.07 (+0.68%)
S&P 500   3,473.86 (+1.37%)
DOW   28,560.38 (+1.29%)
QQQ   286.90 (+1.09%)
AAPL   118.66 (+2.31%)
MSFT   216.24 (+0.94%)
FB   268.77 (+2.82%)
GOOGL   1,556.00 (+1.70%)
AMZN   3,243.68 (+1.14%)
TSLA   428.67 (-0.50%)
NVDA   549.00 (+1.68%)
BABA   311.33 (+1.98%)
CGC   19.21 (-3.03%)
GE   7.37 (+1.10%)
MU   54.12 (+2.83%)
AMD   82.54 (+0.66%)
T   26.94 (+0.22%)
F   7.84 (+3.29%)
ACB   4.51 (-4.25%)
GILD   60.42 (-0.25%)
NFLX   530.11 (-0.11%)
BA   168.39 (+0.77%)
BAC   24.32 (+2.53%)
DIS   125.07 (+0.68%)
S&P 500   3,473.86 (+1.37%)
DOW   28,560.38 (+1.29%)
QQQ   286.90 (+1.09%)
AAPL   118.66 (+2.31%)
MSFT   216.24 (+0.94%)
FB   268.77 (+2.82%)
GOOGL   1,556.00 (+1.70%)
AMZN   3,243.68 (+1.14%)
TSLA   428.67 (-0.50%)
NVDA   549.00 (+1.68%)
BABA   311.33 (+1.98%)
CGC   19.21 (-3.03%)
GE   7.37 (+1.10%)
MU   54.12 (+2.83%)
AMD   82.54 (+0.66%)
T   26.94 (+0.22%)
F   7.84 (+3.29%)
ACB   4.51 (-4.25%)
GILD   60.42 (-0.25%)
NFLX   530.11 (-0.11%)
BA   168.39 (+0.77%)
BAC   24.32 (+2.53%)
DIS   125.07 (+0.68%)
Log in
OTCMKTS:COTQF

Cotinga Pharmaceuticals Short Interest Ratio and Short Volume

$0.03
0.00 (0.00 %)
(As of 10/19/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.03
Now: $0.03
$0.03
50-Day Range
$0.02
MA: $0.03
$0.04
52-Week Range
$0.01
Now: $0.03
$0.25
VolumeN/A
Average Volume7,248 shs
Market Capitalization$681,566.00
P/E RatioN/A
Dividend YieldN/A
Beta1.13

Short Interest

Cotinga Pharmaceuticals (OTCMKTS:COTQF) Short Interest Data

Current Short Volume:53,600 shares
Previous Short Volume:400 shares
Change Vs. Previous Month:+13,300.00%
Dollar Volume Sold Short:$1,608.00
Short Interest Ratio / Days to Cover:4.0
Last Record Date:September, 30 2020
Outstanding Shares:21,986,000 shares
Short Percent of Float:0.00%
Today's Trading Volume:0 shares
Average Trading Volume:7,248 shares
Today's Volume Vs. Average:-100.00%



Cotinga Pharmaceuticals (OTCMKTS:COTQF) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
9/30/202053,600 $1,608.00 13,300.0%0.0%3.5$0.03
9/15/2020400 $12.00 0.0%0.0%4$0.03
8/14/20205,100 $0.00 0.0%0.0%51$0.00
7/31/20205,100 $0.00 2.0%0.0%25.5$0.00
7/15/20205,000 $150.00 0.0%0.0%25$0.03
6/30/20205,000 $200.00 0.0%0.0%1.4$0.04
6/15/20205,000 $0.00 0.0%0.0%0$0.00
5/29/20205,000 $150.00 0.0%0.0%0.9$0.03
5/15/20205,000 $200.00 0.0%0.0%0$0.04
4/30/20205,000 $100.00 0.0%0.0%12.5$0.02
3/31/202019,400 $582.00 102.1%0.0%6.3$0.03
3/13/20209,600 $480.00 0.0%0.0%48$0.05
2/28/20209,600 $0.00 0.0%0.0%3.3$0.00
2/14/20209,600 $384.00 11.6%0.0%13.7$0.04
1/31/20208,600 $0.00 -3.4%0.0%14.3$0.00
1/15/20208,900 $356.00 12.7%0.0%12.7$0.04
12/31/20197,900 $316.00 -18.6%0.0%5.6$0.04

Cotinga Pharmaceuticals (OTCMKTS:COTQF) Short Interest FAQ

speech bubbles
speech bubbles











What is Cotinga Pharmaceuticals' current short interest?

Short interest is the volume of Cotinga Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of September 30th, investors have sold 53,600 shares of COTQF short. 0.00% of Cotinga Pharmaceuticals' shares are currently sold short. View details.

What is a good short interest ratio for Cotinga Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Cotinga Pharmaceuticals currently has a short interest ratio of 4.0.

Is Cotinga Pharmaceuticals' short interest increasing or decreasing?

Cotinga Pharmaceuticals saw a increase in short interest in September. As of September 30th, there was short interest totaling 53,600 shares, an increase of 13,300.0% from the previous total of 400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Cotinga Pharmaceuticals' short interest compare to its competitors?

0.00% of Cotinga Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Cotinga Pharmaceuticals: Amarantus BioScience Holdings, Inc. (0.00%), Parnell Pharmaceuticals Holdings Ltd (0.00%), Cardax, Inc. (0.00%), Propanc Biopharma Inc (0.00%), ImmunoCellular Therapeutics, Ltd. (0.00%), Earth Science Tech, Inc. (0.00%), Peak Pharmaceuticals, Inc. (0.00%), Boston Therapeutics Inc (0.00%), MusclePharm Co. (0.00%), and Immune Pharmaceuticals, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications Inc ($5.12 billion), Aon PLC ($3.76 billion), Clorox Co ($3.07 billion), ViacomCBS Inc. ($2.89 billion), Analog Devices, Inc. ($2.49 billion), Moderna, Inc. ($2.37 billion), Datadog ($2.29 billion), Uber Technologies, Inc. ($2.22 billion), Kroger Co ($2.20 billion), and Simon Property Group Inc ($1.88 billion). View all of the most shorted stocks.

What does it mean to sell short Cotinga Pharmaceuticals stock?

Short selling COTQF is an investing strategy that aims to generate trading profit from Cotinga Pharmaceuticals as its price is falling. To short Cotinga Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Cotinga Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Cotinga Pharmaceuticals?

A short squeeze for Cotinga Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of COTQF, which in turn drives the price of the stock up even further.

How often is Cotinga Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including COTQF, twice per month. The most recent reporting period available is September, 30 2020.


This page was last updated on 10/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.